Has Anthropic said which diseases it will target first?

No. Anthropic has provided very few specific details about what it hopes to accomplish in drug development, and the company did not respond to requests for comment about which diseases it plans to target first.

Will Anthropic partner with other companies for drug testing and trials?

That is unclear. Anthropic did not respond to questions about whether it would partner with other companies for lab work, animal testing, clinical trials, or manufacturing.

How far away is an AI-designed drug from reaching patients?

Experts say the field is a long way off from an AI-designed drug being approved by regulators for human use. Any drug candidate would take at least the better part of a decade given how long it takes a new drug to go through clinical trials, and no AI-designed drug has yet made it through clinical trials and FDA approval to reach market.

Large Language ModelsAI Business & IndustryThe Verge AIJul 3, 2026Jul 4, 2026, 01:00 JST

Anthropic to develop drugs itself, selling AI tools to rivals

Send on LINE

3 Key Points

What happened
Anthropic announced Claude Science, an AI workbench for scientists, at an event this week, and said it would develop drugs of its own, focusing on treatments for "neglected" diseases. The company is actively hiring biologists and building wet labs.
Why it matters
Anthropic is taking a more direct approach to pharma than competitors like OpenAI, Google, and Amazon, which offer life sciences tools but do not develop drugs themselves. This puts Anthropic in the unusual position of selling software to potential drug-development rivals while competing with them as a drugmaker.
What to watch
No AI-designed drug has yet reached the market through clinical trials and FDA approval. Experts say any drug candidate Anthropic develops is likely a decade or more away, since the real-world testing and clinical trials phase is slow and expensive, and many promising candidates fail during human testing.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Get news like this every morning, free

FAQ

Has Anthropic said which diseases it will target first?: No. Anthropic has provided very few specific details about what it hopes to accomplish in drug development, and the company did not respond to requests for comment about which diseases it plans to target first.
Will Anthropic partner with other companies for drug testing and trials?: That is unclear. Anthropic did not respond to questions about whether it would partner with other companies for lab work, animal testing, clinical trials, or manufacturing.
How far away is an AI-designed drug from reaching patients?: Experts say the field is a long way off from an AI-designed drug being approved by regulators for human use. Any drug candidate would take at least the better part of a decade given how long it takes a new drug to go through clinical trials, and no AI-designed drug has yet made it through clinical trials and FDA approval to reach market.

The Verge AIRead Original Article

Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Get it free

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.